8466 related articles for article (PubMed ID: 2127098)
1. Effect of interferon-gamma on the expression of HLA-DR by human melanoma cells of varying metastatic potential.
Hendrix MJ; Seftor EA; Eckes MD; Winters AL; Leong SP; Scuderi P
Pigment Cell Res; 1990 Sep; 3(3):162-7. PubMed ID: 2127098
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
[TBL] [Abstract][Full Text] [Related]
3. Induction of ICAM-1 and HLA-DR expression by IFN-gamma in malignant melanoma cell lines.
Kim JD; Lee JL; Park JH; Lee JM; Kim YH; Kim SJ
Yonsei Med J; 1995 Mar; 36(1):15-25. PubMed ID: 7740833
[TBL] [Abstract][Full Text] [Related]
4. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
5. Pattern of expression of HLA-DR and HLA-DQ antigens and mRNA in myeloid differentiation.
Amatruda TT; Bohman R; Ranyard J; Koeffler HP
Blood; 1987 Apr; 69(4):1225-36. PubMed ID: 3103718
[TBL] [Abstract][Full Text] [Related]
6. The antagonistic effect of interferon-beta on the interferon-gamma-induced expression of HLA-DR antigen in a squamous cell carcinoma line.
Naito Y; Baba T; Suzuki H; Uyeno K
J Exp Pathol; 1992; 6(1-2):75-87. PubMed ID: 1625040
[TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
[TBL] [Abstract][Full Text] [Related]
8. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
[TBL] [Abstract][Full Text] [Related]
9. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
Carrel S; Schmidt-Kessen A; Giuffrè L
Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
[TBL] [Abstract][Full Text] [Related]
10. Induction of ICAM-1, HLA-DR molecules by IFN-gamma and oncogene expression in human bladder cancer cell lines.
Park DS; Park JH; Lee JL; Lee JM; Kim YH; Lee JM; Kim SJ
Urol Int; 1997; 59(2):72-80. PubMed ID: 9392053
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the HLA-DR genes in various melanoma cell lines treated with interferon-gamma: methylation of the HLA-DR alpha gene in these lines is not correlated with its expression.
Carrington MN; Chedid M; Ting JP; Ward FE
Hum Immunol; 1987 Feb; 18(2):151-61. PubMed ID: 3104241
[TBL] [Abstract][Full Text] [Related]
12. Effect of gamma interferon on HLA class-I and -II transcription and protein expression in human breast adenocarcinoma cell lines.
Jabrane-Ferrat N; Faille A; Loiseau P; Poirier O; Charron D; Calvo F
Int J Cancer; 1990 Jun; 45(6):1169-76. PubMed ID: 2112515
[TBL] [Abstract][Full Text] [Related]
13. Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control.
Rosa FM; Fellous M
J Immunol; 1988 Mar; 140(5):1660-4. PubMed ID: 3126233
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
Maio M; Gulwani B; Morgano A; Ferrone S
Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon.
Rosa F; Hatat D; Abadie A; Wallach D; Revel M; Fellous M
EMBO J; 1983; 2(9):1585-9. PubMed ID: 11892816
[TBL] [Abstract][Full Text] [Related]
17. Correlation of class II transactivator with HLA-DR antigen and its implications.
Xu KL; Li H; Pan XY; Li ZY; Lu QX; Zhang Y; Zhu HH; DU B; Zeng LY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):147-51. PubMed ID: 17490542
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous expression of thyroid peroxidase and human leukocyte antigen-DR by human thyroid cells: modulation by thyrotropin, thyroid-stimulating antibody, and interferon-gamma.
Chiovato L; Lapi P; Mariotti S; Del Prete G; De Carli M; Pinchera A
J Clin Endocrinol Metab; 1994 Aug; 79(2):653-6. PubMed ID: 7913937
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of MHC class II genes in lung tumour cell lines.
Redondo M; Ruiz-Cabello F; Concha A; Hortas ML; Serrano A; Morell M; Garrido F
Eur J Immunogenet; 1998 Dec; 25(6):385-91. PubMed ID: 9949943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
